Skip to Main Content
Qurgen Qurgen
Menu Button

Oct. 14, 2024

Brand Icon
 The China CDE officially approved the investigational new drug application of Suzhou Fuent Pharmaceutcal Co., Ltd., with the CDE acceptance number: CXSL2400508. 

Recent important news

Mar. 2026
Qurgen is happy to announce that the blood and biopsy tissue results of a late-stage of ocular melanoma...
Learn More
Jan. 13, 2026
Dr. Chai Yan Joins Qurgen/Fuent as Senior Vice President for BP，Qurgen, CEO，Suzhou Fuent Pharmaceutics and...
Learn More